Glossy · April 2026
Injectable research peptides move from niche biohacker protocol to mainstream demand.
Trade publication Glossy documents how injectable research peptides like BPC-157 and TB-500 have crossed into the mainstream, driving a wave of new wellness businesses built to meet demand. The piece situates peptides alongside the broader normalisation of peptide skincare and GLP-1 therapies as part of a wider cultural shift.
“2026 is the year of peptides.”
Glossy, 2026
External media coverage is cited for context only. Mercia Research supplies compounds for laboratory research use only and does not endorse or advise human use.